latest news in companies
International Petroleum Corporation Beats Expectations Following Early Oil Project Launch
Toronto, Tuesday, 4 August 2026.
International Petroleum Corporation reported second-quarter earnings per share of $0.39, easily beating expectations as early oil production at its flagship Canadian Blackrod project boosted operational performance.
HSBC Exceeds Expectations with $19.5 Billion Profit and Resumes Stock Buybacks
London, Tuesday, 4 August 2026.
HSBC reported a first-half pretax profit of $19.5 billion, beating market estimates. Driven by strong wealth management fees, the bank launched a $1 billion share buyback and raised income guidance.
European Regulators Approve Sanofi Meningitis Vaccine for Infants as Young as Six Weeks
Paris, Tuesday, 4 August 2026.
The European Commission expanded approval for Sanofi’s MenQuadfi vaccine to six-week-old infants, broadening early protection against a rapid, severe disease carrying a mortality rate up to 15 percent.
Nurix Therapeutics Begins Pivotal Phase 3 Trial Testing Novel Leukemia Treatment Against Key Competitor
San Francisco, Tuesday, 4 August 2026.
On August 4, 2026, Nurix Therapeutics enrolled the first patient in a Phase 3 trial evaluating its targeted protein degrader, bexobrutideg, head-to-head against Eli Lilly’s pirtobrutinib for chronic leukemia.
Finland's IQM Quantum Computers Reports First Public Earnings With over €102 Million Order Backlog
Espoo, Tuesday, 4 August 2026.
IQM Quantum Computers delivered its inaugural earnings report as a public company, showcasing a massive €102.1 million order backlog that highlights surging demand for commercial quantum hardware.
Eli Lilly Drug Earns Fast-Track FDA Status for Pancreatic Cancer
Indianapolis, Tuesday, 4 August 2026.
Eli Lilly received FDA Breakthrough Therapy designation for olomorasib to treat advanced pancreatic cancer. This marks the drug’s second fast-track status, addressing a fatal condition with no current approved targeted options.
